SSRIs inhibit platelet function in patients with chronic heart failure (HF) receiving aspirin therapy

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1406, 2003-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosiglitazone may increase the risk of chronic heart failure (HF) in patients receiving insulin for type 2 diabetes mellitus

Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Aspirin safe in patients with HF receiving ACE inhibitors

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Immunomodulation therapy in patients with chronic heart failure

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Thiazolidinediones may double the risk of heart failure (HF) among patients receiving such drugs for type 2 diabetes mellitus

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure: Pathophysiology and Current Experience

By Seidl K. Rameken M. Vater M. Senges J.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 219-226

Adis International

Access to resources Recommend Favorite